Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations
Chapter 2 Executive Summary
Chapter 3 Market Overview
3.1 Market Trends and Future Outlook
3.2 Global Cell Surface Markers Market Revenues, by Instruments and Reagents, 2011 – 2019 (USD Million)
3.3 Drivers
3.3.1 Growing Automation in Laboratories
3.3.2 Discovery of New Markers will Need New Antibodies
3.3.3 Increased Use of In Vitro Diagnostics
3.3.4 Need for Lowering Healthcare Expenditure
3.4 Restraints
3.4.1 Reluctance for High Investment in Sophisticated Models
3.4.2 Complexity in the Use of Flow Cytometers
3.5 Opportunities
3.5.1 Growth in Expertise for Operation of Cell Marking Tools
3.5.2 Targeted Therapy and Personalized Medicine
3.6 Porter’s Five Force Analysis for the Global Cell Surface Markers Market
3.6.1 Bargaining Power of Suppliers
3.6.2 Bargaining Power of Buyers
3.6.3 Threat of New Entrants
3.6.4 Threat of Substitutes
3.6.5 Competitive Rivalry
3.7 Market Attractiveness Analysis of Global Cell Surface Markers Market, by Instruments and Reagents, 2012
Chapter 4 Global Cell Surface Markers Market, by Instruments and Reagents
4.1 Overview – Current Market Scenario and Future Market Trends
4.1.1 Global Cell Surface Markers Market Revenues, 2011 – 2019 (USD Million)
4.2 Flow Cytometry
4.2.1 Global Flow Cytometers Market Revenues, 2013 – 2019 (USD Million)
4.2.2 Global Flow Cytometers Market Volume, 2013 – 2019 (Number of Units Installed)
4.3 Hematology Analyzers
4.3.1 Global Hematology Analyzers Market Revenues, 2011 – 2019 (USD Million)
4.3.2 Global Hematology Analyzers Market Volume, 2013 – 2019 (Number of Units Installed)
4.4 Reagents and Kits
4.4.1 Global Reagent and Kits Market Revenues, 2011 – 2019 (USD Million)
Chapter 5 Global Cell Surface Markers Market, by Applications
5.1 Disease Diagnosis
5.1.1 Global Cell Surface Markers Market Revenues, by Disease Diagnosis and Identification, 2011 – 2019 (USD Million)
5.2 Research and Drug Discovery
5.2.1 Global Cell Surface Markers Market Revenues, by Research and Drug Discovery, 2011 – 2019 (USD Million)
Chapter 6 Global Cell Surface Markers Market, by Geography
6.1 Introduction
6.2 North America
6.2.1 North America Cell Surface Markers Market Revenues, 2011 – 2019 (USD Million)
6.3 Europe
6.3.1 Europe Cell Surface Markers Market Revenues, Size and Forecast, 2011 – 2019 (USD Million)
6.4 Asia-Pacific
6.4.1 Asia-Pacific Cell Surface Markers Market Revenues, 2011 – 2019 (USD Million)
6.5 Rest of the World (RoW)
6.5.1 Rest of the World (RoW) Cell Surface Markers Market Revenues, Size and Forecast, 2011 – 2019 (USD Million)
Chapter 7 Recommendations
Chapter 8 Company Profiles
8.1 Abbott Laboratories, Inc.
8.1.1 Company Overview
8.1.2 Strategic Overview
8.1.3 Financial Overview
8.1.4 Product Portfolio
8.1.5 Recent Developments
8.2 Beckman Coulter, Inc.
8.2.1 Company Overview
8.2.2 Strategic Overview
8.2.3 Financial Overview
8.2.4 Product Portfolio
8.2.5 Recent Developments
8.3 BD Biosciences
8.3.1 Company Overview
8.3.2 Strategic Overview
8.3.3 Financial Overview
8.3.4 Product Portfolio
8.3.5 Recent Development
8.4 Bio-Rad Laboratories, Inc.
8.4.1 Company Overview
8.4.2 Strategic Overview
8.4.3 Financial Overview
8.4.4 Product Portfolio
8.4.5 Recent Development
8.5 Grifols SA
8.5.1 Company Overview
8.5.2 Strategic Overview
8.5.3 Financial Overview
8.5.4 Product Portfolio
8.5.5 Recent Development
8.6 Immucor, Inc.
8.6.1 Company Overview
8.6.2 Strategic Overview
8.6.3 Financial Overview
8.6.4 Product Portfolio
8.6.5 Recent Developments
8.7 Janssen Diagnostics, Inc.
8.7.1 Company Overview
8.7.2 Strategic Overview
8.7.3 Financial Overview
8.7.4 Product Portfolio
8.7.5 Recent development
8.8 Nihon Kohden Corporation
8.8.1 Company Overview
8.8.2 Strategic Overview
8.8.3 Financial Overview
8.8.4 Product Portfolio
8.8.5 Recent developments
8.9 F. Hoffmann-La Roche Ltd.
8.9.1 Company Overview
8.9.2 Strategic Overview
8.9.3 Financial Overview
8.9.4 Product Portfolio
8.9.5 Recent Developments
8.10 Siemens Healthcare
8.10.1 Company Overview
8.10.2 Strategic Overview
8.10.3 Financial Overview
8.10.4 Product Portfolio
8.10.5 Recent Developments
8.11 Sysmex Corporation
8.11.1 Company Overview
8.11.2 Strategic Overview
8.11.3 Financial Overview
8.11.4 Product Portfolio
8.11.5 Recent Development
8.12 Thermo Fischer Scientific, Inc.
8.12.1 Company Overview
8.12.2 Strategic Overview
8.12.3 Financial Overview
8.12.4 Product Portfolio
8.12.5 Recent Development
LIST OF TABLE
TABLE 1 Market Snapshot: Global Cell Surface Markers Market
TABLE 2 Global Cell Surface Markers Market Revenues, by Instruments and Reagents, 2011 – 2019 (USD Million)
TABLE 3 Global Cell Surface Markers Market Revenues, by Geography, Size and Forecast, 2013-2019 (USD Million)
TABLE 4 North America Cell Surface Markers Market Revenues, by Instruments and Reagents, 2011 – 2019 (USD Million)
TABLE 5 Europe Cell Surface Markers Market Revenues, By Instruments and Reagents, 2011 – 2019 (USD Million)
TABLE 6 Asia-Pacific Cell Surface Markers Market Revenues, By Instruments and Reagents, 2011 – 2019 (USD Million)
TABLE 7 RoW Cell Surface Markers Market Revenues, By Instruments and Reagents, 2011 – 2019 (USD Million)
LIST OF FIGURE
FIG. 1 Cell Surface Markers: Market Segmentation
FIG. 2 Global Cell Surface Markers Market Revenues, by Instruments and Reagents, 2012 (USD Million)
FIG. 3 Global Cell Surface Markers Market Revenues, by Geography, 2012 (USD Million)
FIG. 4 Porter’s Five Force Analysis: Global Cell Surface Markers Market
FIG. 5 Market Attractive Analysis: Global Cell Surface Markers Market, by Instruments and Reagents, 2012
FIG. 6 Global Cell Surface Markers Market Revenues, 2011 – 2019 (USD Million)
FIG. 7 Global Flow Cytometers Market Revenues, 2011 - 2019 (USD Million)
FIG. 8 Global Flow Cytometers Market Volume, 2011 – 2019 (Number of Units Installed)
FIG. 9 Global Hematology Analyzers Market Revenues, 2011 - 2019 (USD Million)
FIG. 10 Global Hematology Analyzers Market Volume, 2011 – 2019 (Number of Units Installed)
FIG. 11 Global Reagents and Kits Market Revenues, 2011 - 2019 (USD Million)
FIG. 12 Global Cell Surface Markers Market Revenues, by Disease Diagnosis and Identification, 2011 - 2019 (USD Million)
FIG. 13 Global Cell Surface Markers Market Revenues, by Research and Drug Discovery, 2011 - 2019 (USD Million)
FIG. 14 North America Cell Surface Markers Market Revenues, 2011 - 2019 (USD Million)
FIG. 15 Europe Cell Surface Markers Market Revenues, 2011 - 2019 (USD Million)
FIG. 16 Asia-Pacific Cell Surface Markers Market Revenues, 2011 - 2019(USD Million)
FIG. 17 Rest of the World (RoW) Cell Surface Markers Market Revenues, 2011 - 2019 (USD Million)
FIG. 18 Annual Revenues of Abbott Laboratories, Inc., 2010 – 2012 (USD Million)
FIG. 19 Annual Revenues of Bio-Rad Laboratories, Inc., 2010 – 2012 (USD Million)
FIG. 20 Annual Revenues of Grifols SA, 2010 – 2012 (USD Million)
FIG. 21 Annual Revenues of Immucor, Inc., 2010 – 2012 (USD Million)
FIG. 22 Annual Revenues of Nihon Kohden Corp., 2010 – 2012 (USD Million)
FIG. 23 Annual Revenues of Hoffmann-La Roche Ltd., 2010 – 2012 (USD Million)
FIG. 24 Annual Revenues of Siemens Healthcare, 2010 – 2012 (USD Million)
FIG. 25 Annual Revenues of Sysmex Corporation, 2010 – 2012 (USD Million)
FIG. 26 Annual Revenues of Thermo Fischer Scientific, Inc., 2010 – 2012 (USD Million)